Rising Cancer Prevalence Drives Growth In Single-Cell Genome Sequencing Market Driver: A Major Catalyst in the Evolution of the Single-Cell Genome Sequencing Market in 2025

What combination of drivers is leading to accelerated growth in the single-cell genome sequencing market?
The rise in cancer cases is predicted to fuel the expansion of the single-cell genome sequencing market. Cancer, which encompasses numerous diseases where rogue cells multiply unchecked, stems from alterations in genes responsible for cell division and maintenance of regular cell functions. Being a disease marked by genetic changes, single-cell genome sequencing could reveal genetic modifications in individual cancer cells. For example, the American Cancer Society, a US-based organization battling cancer, reported close to 1.9 million novel cancer cases and 609,360 cancer-related fatalities in the US in 2022 alone, as of January 2023. Moreover, an anticipated 27.5 million fresh cancer cases and 16.3 million cancer-related deaths are projected by 2040. Consequently, the escalating incidence of cancer is projected to drive the growth of the single-cell genome sequencing market.

Get Your Single-Cell Genome Sequencing Market Report Here:
https://www.thebusinessresearchcompany.com/report/single-cell-genome-sequencing-global-market-report

What is the projected compound annual growth rate (CAGR) of the single-cell genome sequencing market from 2025 to 2034, and what factors influence it?
There has been a swift expansion in the market size of single-cell genome sequencing in recent years. The market is projected to increase from $2.49 billion in 2024 to $2.84 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 13.9%. The growth during the historic period is primarily due to improved comprehension of genetic heterogeneity, a surging demand for precision medicine, an escalation in cancer research, an increase in the prevalence of infectious diseases, and greater expenditure on healthcare.

Expectations for the single-cell genome sequencing market point towards a remarkable growth trajectory in coming years, with projections reaching as high as $5.04 billion in 2029 and a CAGR of 15.4%. This anticipated surge within the forecasted timeframe can be credited to a rise in autoimmune diseases, an increase in neurological disorders, enhanced government initiatives and funding, the expansion of contract research organizations (CROs), and heightened awareness of the possibilities with scrna-seq. The period will also witness key trends such as advancements in single-cell sequencing technologies, the birth of single-cell multi-omics technologies, cooperative efforts to expedite advancements, innovative solutions and strategic partnerships among major players in the market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12655&type=smp

What trends are poised to drive the future success of the single-cell genome sequencing market?
The rise in technological advancements is a noteworthy trend emerging in the single-cell genome sequencing market. Preeminent firms managing this market are concentrating on the development of high-tech solutions to reinforce their market standing. An illustration of this is Mission Bio Inc., a US enterprise that integrates genotype and phenotype for cancer investigation and biomarker creation, who launched Tapestri Genome Editing Solution in May 2023. This new product for genome editing analysis exhibits potential to act as a superior analytical instrument for creating next-gen gene-edited drugs. It achieves this by providing single-cell insights that can alter efficacy and safety.

What are the major segments of the single-cell genome sequencing market and their role in driving growth?
The single-cell genome sequencing market covered in this report is segmented -

1) By Type: Instruments, Reagents
2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Quantitative Polymerase Chain Reaction (qPCR), Microarray, Multiple Displacement Amplification (MDA)
3) By Disease Area: Cancer, Immunology, Prenatal Diagnosis, Neurobiology, Microbiology, Other Disease Areas
4) By Application: Circulating Cells, Cell Differentiation Or Reprogramming, Genomic Variation, Subpopulation Characterization, Other Applications
5) By End User: Academic Research Laboratories, Biotechnology Biopharmaceutical Companies, Clinics, Other End Users

Subsegments:
1) By Instruments: Single-Cell Isolation Systems, Sequencing Platforms, Automation And Robotic Systems
2) By Reagents: Library Preparation Kits, Amplification Reagents, DNA Extraction Kits, Quality Control Reagents

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12655

Which regions are key players in the growth of the single-cell genome sequencing market?
North America was the largest region in the single-cell genome sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell genome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Who are the key firms paving the way for growth in the single-cell genome sequencing market?
Major companies operating in the single-cell genome sequencing market include F Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., DH Life Sciences LLC., Becton Dickinson And Company (BD), Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN GmbH, Bio-Techne Corporation, BGI Genomics Co. Ltd., Fulgent Genetics Inc., 10x Genomics Inc., Promega Corporation, Takara Bio Inc., Oxford Nanopore Technologies PLC, Pacific Biosciences of California Inc., Standard BioTools Inc., Singleron Biotechnologies, MGI Tech Co. Ltd, GENEWIZ Inc., Mission Bio Inc., Zymo Research Corporation, Menarini Silicon Biosystems SpA, Novogene Co. Ltd., RareCyte Inc., Fluxion Biosciences Inc., Single Cell Discoveries B.V., Parse Biosciences Inc., BioSpyder Technologies Inc., SeqWell Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12655&type=smp

What Is Covered In The Single-Cell Genome Sequencing Global Market Report?

• Market Size Forecast: Examine the single-cell genome sequencing market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the single-cell genome sequencing market for a structured understanding.
• Key Players Overview: Analyze major players in the single-cell genome sequencing market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the single-cell genome sequencing market.
• Segment Contributions: Evaluate how different segments drive overall growth in the single-cell genome sequencing market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the single-cell genome sequencing market.
• Industry Challenges: Identify potential risks and obstacles affecting the single-cell genome sequencing market.
• Competitive Landscape: Review strategic developments in the single-cell genome sequencing market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.